ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Hlavní autor: | R.T. Saygitov |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
"Paediatrician" Publishers LLC
2008-08-01
|
Edice: | Вопросы современной педиатрии |
On-line přístup: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Podobné jednotky
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
Autor: R.T. Saygitov
Vydáno: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
Autor: Cardile S, a další
Vydáno: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
Autor: Yu. V. Yevsyutina
Vydáno: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
Autor: Gold Benjamin D, a další
Vydáno: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
Autor: Roy C Orlando, a další
Vydáno: (2010-09-01)